CN114451425B - Application of fructus forsythiae extract in preventing and treating kiwifruit canker - Google Patents

Application of fructus forsythiae extract in preventing and treating kiwifruit canker Download PDF

Info

Publication number
CN114451425B
CN114451425B CN202210217118.4A CN202210217118A CN114451425B CN 114451425 B CN114451425 B CN 114451425B CN 202210217118 A CN202210217118 A CN 202210217118A CN 114451425 B CN114451425 B CN 114451425B
Authority
CN
China
Prior art keywords
extract
ethanol
fructus forsythiae
butanol
forsythia
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202210217118.4A
Other languages
Chinese (zh)
Other versions
CN114451425A (en
Inventor
龙章富
龙力
裴沪荣
方磊
卢明秀
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sichuan University
Original Assignee
Sichuan University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sichuan University filed Critical Sichuan University
Priority to CN202210217118.4A priority Critical patent/CN114451425B/en
Publication of CN114451425A publication Critical patent/CN114451425A/en
Application granted granted Critical
Publication of CN114451425B publication Critical patent/CN114451425B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N65/00Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01GHORTICULTURE; CULTIVATION OF VEGETABLES, FLOWERS, RICE, FRUIT, VINES, HOPS OR SEAWEED; FORESTRY; WATERING
    • A01G13/00Protecting plants
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N65/00Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
    • A01N65/08Magnoliopsida [dicotyledons]

Abstract

The invention discloses application of a forsythia suspense extract in preventing and treating kiwifruit canker caused by pseudomonas syringae kiwifruit pathogenic variety, wherein the forsythia suspense extract is an ethanol extract of forsythia suspense or an n-butanol re-extraction extract of the ethanol extract of forsythia suspense. The forsythia suspense extract provided by the invention has an inhibitory activity effect on kiwi canker pathogenic bacteria, and is expected to be developed into a pollution-free plant-derived pathogenic bacteria inhibiting and killing agent due to the characteristics that the forsythia suspense raw material has wide sources, is non-toxic to human bodies, is harmless to crops and has easy degradation when being used as a plant-derived pathogenic bacteria inhibiting and killing agent.

Description

Application of fructus forsythiae extract in preventing and treating kiwifruit canker
Technical Field
The invention belongs to the field of plant pesticides, and particularly relates to application of a forsythia suspense extract to prevention and treatment of kiwifruit canker.
Background
Plant diseases are an important factor affecting agricultural production, and different pathogenic bacteria can cause diseases of various crops, which causes great loss to agricultural economy. The kiwifruit canker is a destructive bacterial disease seriously threatening the production of kiwifruit and is listed as a national forest plant quarantine object. The disease is fierce in coming, causes damage to the whole garden due to epidemic years, causes great economic loss, reduces yield, causes fruit peel thickening, turns sour fruit taste, reduces fruit size, varies fruit shape, reduces quality and reduces commodity value. The commercialization of agricultural chemicals began in the early days, but the agricultural chemicals were chemical ones at that time, and the rapid development of agricultural chemicals brought a great benefit in the yield and quality of agricultural products. However, with the continuous popularization and application of chemical pesticides, the harm caused by the chemical pesticides is not negligible. The use of a large amount of chemical pesticides can cause serious pollution to the environment, can cause damage to non-target organisms, and can cause harm to the health of human beings due to pesticide residues. With the improvement of the life quality of people, more attention is paid to food safety. Therefore, in order to enable agriculture to develop sustainable health, the development of new pesticides which do not harm the environment and human health becomes an important task for pesticide research, biological pesticides becomes a research hotspot of modern agriculture development, and plant-derived pesticides are an important field in biological pesticides. Because the plant source pesticide has the following characteristics: the earth has rich plant resources and various varieties; different from chemical pesticides, the biological pesticide of plant source has stronger pertinence and cannot cause damage to non-target organisms; the plant source extract has diversified components, the active components have synergistic effect, and the action targets of different active components on diseases are different, so compared with chemical pesticides, when the plant source biological pesticide is adopted, pathogenic bacteria are not easy to generate drug resistance on the pesticide; since the botanical pesticide is a natural product derived from nature, the botanical pesticide can be naturally digested in nature, and substances destructive to the environment can not be generated, so that the development of the efficient biopesticide has important significance for protecting ecological environment, human and animal health.
Since 2008 pseudomonas syringae kiwifruit pathogenic variety (Psa) has been threatening the world kiwifruit industry, destroying orchards in europe, south america, and new zealand. The "kiwifruit canker disease" caused by pseudomonas syringae kiwifruit pathovar cata (Psa) was first reported in italy and it has resulted in economic losses of tens of millions of dollars in the next four years. The disease is quick in outbreak and causes serious loss to the kiwi fruit producing areas all around the world. At present, chemical agents are mainly applied to control kiwifruit canker in production, and researches show that Psa has generated resistance to partial pesticides.
Disclosure of Invention
The technical problem to be solved by the invention is as follows: how to provide a new plant-source antibacterial drug source for preventing and treating kiwifruit canker caused by pseudomonas syringae kiwifruit pathogenic variety.
The technical scheme of the invention is as follows: use of a forsythia suspense extract for the control of kiwifruit canker disease caused by pseudomonas syringae kiwifruit pathogenic varieties, the forsythia suspense extract being any one of the following:
a. an ethanol extract of the fruit of weeping forsythia,
b. n-butanol re-extraction of ethanol extract of fructus forsythiae.
The raw material of the forsythia is the fruit or the whole plant of the forsythia.
Further, the ethanol extract adopts ethanol with volume fraction of not less than 75%. Further 90-98% ethanol, preferably 95% ethanol.
Further, the n-butanol re-extract of the ethanol extract of forsythia is prepared by the following method:
(1) leaching the dried and crushed fructus forsythiae with 95% ethanol for 12-24 hours, then ultrasonically extracting at 45-50 ℃ for 4-6 hours to fully leach active ingredients in the fructus forsythiae, and collecting leaching liquor;
(2) concentrating the collected leaching solution to obtain ethanol extract of fructus forsythiae, and recovering ethanol as solvent;
(3) extracting the ethanol extract of fructus forsythiae with n-butanol, and concentrating to obtain n-butanol extract.
Further, the n-butanol extract was concentrated using vacuum at 35 ℃.
The forsythia extract for inhibiting and killing kiwifruit canker disclosed by the invention can be used for preparing a preparation for inhibiting and killing kiwifruit canker pathogenic bacteria. Wherein the ethanol extract of fructus forsythiae or N-butanol re-extract of the ethanol extract of fructus forsythiae can be directly used for preparing a preparation for inhibiting and killing pathogenic bacteria of kiwifruit ulcer after dissolving in N, N-dimethylformamide.
Compared with the prior art, the invention has the following beneficial effects:
1. the fructus forsythiae active component for inhibiting and killing the pathogenic bacteria of the kiwifruit ulcer disclosed by the invention can be prepared into the inhibiting and killing preparation of the pathogenic bacteria of the kiwifruit ulcer in the dosage forms of aqueous solution, soluble powder, wettable powder, concentrated suspension, granules and the like. The preparation method of various dosage forms is a conventional method in the field, and the used auxiliary agent in the preparation process of various dosage forms is a common auxiliary agent in the field of pesticides. The concentration of fructus forsythiae extract in the solution prepared by the dosage forms during use is in the range of 0.1mg/mL-1000 mg/mL.
2. The forsythia suspense extract provided by the invention has an inhibitory activity effect on kiwi canker pathogenic bacteria, and is expected to be developed into a pollution-free plant-derived pathogenic bacteria inhibiting and killing agent due to the characteristics that the forsythia suspense raw material has wide sources, is non-toxic to human bodies, is harmless to crops and has easy degradation when being used as a plant-derived pathogenic bacteria inhibiting and killing agent.
Drawings
FIG. 1 anti-PSA activity of different extracts of Forsythia suspensa; 1 is n-butanol extract, 2 is ethanol extract, 3 is ethyl acetate extract, and 4 is petroleum ether extract
FIG. 2 comparison of anti-PSA activity of alcoholic forsythia extract with other plant extracts;
Detailed Description
The experimental procedures in the following examples are conventional unless otherwise specified. The test materials used in the following examples were all commercially available unless otherwise specified.
Example 1 preparation of Total ethanol extract of Forsythia suspense and re-extract of petroleum ether, re-extract of ethyl acetate, re-extract of n-butanol
1. Pulverizing dried fructus forsythiae, and sieving with 40 mesh sieve to obtain fructus forsythiae powder.
2. 95% ethanol (not less than 75%, typically 90-98%) in an amount corresponding to about 7 times (typically controlled in the range of 5-10 times) the mass of the feedstock was extracted at room temperature (typically at a temperature in the range of 18-24 ℃) for about 20 hours (typically controlled in the range of 12-24 hours).
3. Ultrasonic waves are carried out for 6h (generally controlled in the range of 4-8h) at about 50 ℃. Filtering with Buchner funnel under negative pressure, and removing residue to obtain filtrate.
4. Further extracting the residue with 95% ethanol with volume of about 6 times (generally 5-10 times) of the raw material for 6 hr (generally 4-8 hr) to extract active components from fructus forsythiae, filtering with Buchner funnel under negative pressure, and removing residue to obtain filtrate.
5. Combining the filtrates, concentrating the filtrate with rotary evaporator in water bath at about 50 deg.C (generally controlled at 45-55 deg.C) to obtain ethanol extract, and storing at 4 deg.C.
6. Taking 20g of fructus forsythiae extract, adding 10 times of n-butanol for extraction, filtering by using filter paper to obtain filtrate, adding n-butanol with proper volume into the residual solid for repeated extraction, and filtering by using filter paper to obtain filtrate. Until the extract is colorless, and vacuum concentrating the filtrate at 35 deg.C with rotary evaporator to obtain n-butanol re-extract of fructus forsythiae alcohol extract.
7. And (3) taking 20g of forsythia ethanol extract, adding 10 times of ethyl acetate for extraction, filtering by using filter paper to obtain filtrate, adding the ethyl acetate with proper volume into the residual solid again for repeated extraction, and filtering by using the filter paper to obtain the filtrate. Until the extract is colorless, concentrating all the obtained filtrate at 35 deg.C under vacuum with rotary evaporator to obtain ethyl acetate extract of fructus forsythiae alcohol extract.
8. And (3) taking 20g of forsythia ethanol extract, adding petroleum ether with the volume 10 times that of the forsythia ethanol extract for extraction, filtering by using filter paper to obtain filtrate, adding petroleum ether with the proper volume into the residual solid again for repeated extraction, and filtering by using the filter paper to obtain the filtrate. Until the extract is colorless, concentrating all the obtained filtrate at 35 deg.C under vacuum with rotary evaporator to obtain petroleum ether re-extract of fructus forsythiae alcoholic extract.
EXAMPLE 2 determination of biological Activity
Under the condition of separation, the antibacterial activity of each extract on pseudomonas syringae kiwi fruit pathogenic variant (Psa) is compared by a filter paper sheet method. Firstly, selecting common chemical qualitative filter paper, preparing the filter paper into a circular filter paper sheet with the diameter of 6mm by using a puncher, and putting the circular filter paper sheet into a centrifugal tubeAnd after high-pressure steam sterilization, drying for later use. Transferring the Psa strain to an LB solid plate for activation, inoculating a single colony into an LB liquid culture medium by using an aseptic inoculating loop after 2-3 times of activation, carrying out shake culture at 25 ℃ and 120rpm/min for 24h, sucking bacterial liquid, and diluting the bacterial liquid with the LB liquid culture medium to the concentration of 1 × 107CFU/mL. Under the aseptic condition, sucking 100 mul of diluted bacterial suspension, uniformly coating the diluted bacterial suspension on an LB solid plate, standing for 2-3 minutes, clamping sterilized filter paper sheets by using sterile forceps, and pasting the filter paper sheets on the surface of the LB solid plate, wherein 3 filter paper sheets are uniformly placed on each plate and are arranged in a regular triangle. A small amount of the four forsythia extractum prepared in example 1 is prepared into a solution with the concentration of 100mg/mL by using N, N-dimethylformamide to serve as a sample for standby experiment.
Respectively sucking 5 mu L of each liquid medicine (the medicine content is 0.5mg), dripping the liquid medicine on a filter paper sheet, marking the liquid medicine, taking the treatment of dripping 5 mu L of dimethyl sulfoxide as a blank control and the treatment of dripping 5 mu L of streptomycin sulfate with the concentration of 50mg/mL as a positive control, and repeating each treatment for three times. The flat plate after adding the medicine is kept stand for 1h at room temperature, and then is put into a constant temperature incubator with the temperature of 25 ℃ for 24 h. And taking out the filter paper, observing whether an obvious bacteriostatic zone exists around the filter paper, and measuring the diameter of the bacteriostatic zone. Results are expressed as mean and standard deviation (mean ± SD). The judgment criteria are shown in Table 1
TABLE 1 criteria
Figure BDA0003535418880000041
TABLE 2 bacteriostatic Activity of Forsythia suspensa extract on Psa
Figure BDA0003535418880000042
Note: the diameter of the inhibition zone is expressed by the mean value plus or minus standard deviation; lower case letters indicate significance p < 0.05.
As shown in FIG. 1 and Table 2, it is understood that the inhibitory effect of the re-extract of n-butanol from forsythia on Psa is the best, and at a concentration of 100mg/mL, the zone diameter is 16.53. + -. 0.12mm, the MIC is 0.125mg/mL, and the inhibitory activity exceeds that of ethanol extract of forsythia (MIC is 0.5 mg/mL). Secondly, the extract with stronger inhibitory action is the re-extracted extract of forsythia ethyl acetate, the diameter of the inhibition zone is 14.47 +/-0.21 mm, the effect is slightly lower than that of the ethanol extract, and the extract has significant difference (p is less than 0.05) with the re-extracted extract of n-butyl alcohol. The fructus forsythiae petroleum ether re-extract has poor bacteriostatic action, the diameter of a bacteriostatic zone is 12.67 +/-0.17 mm, and the bacteriostatic activity of the fructus forsythiae petroleum ether re-extract is remarkably different from that of an n-butyl alcohol re-extract (p is less than 0.05). Therefore, the forsythia n-butyl alcohol re-extracted substance has the best bacteriostatic effect on Psa. This indicates that the polarity of the bacteriostatic active substance in forsythia is relatively high and is mainly concentrated in the n-butanol re-extract.
Example 3 MIC determination of minimum inhibitory concentration
The minimum inhibitory concentrations MIC of the ethanol extract and n-butanol re-extract were determined with partial modification to the method of Yang et al [ International Journal of Antimicrobial Agents,2006,27(4):325-330 ]. The concentration of fructus forsythiae extract and re-extract is set to 0, 0.4, 0.8, 1.2, 1.6, 2.0, 2.4, 2.8, 3.2, 3.6 and 4.0mg/mL, and corresponding volume of medicated culture medium (without Psa) is set as blank control and DMSO is set as negative control. Incubated at 28 ℃ for 24h and OD600nm was measured using a microplate reader. The concentration at which the absorbance of the test group was not significantly different from that of the control group was defined as the minimum inhibitory concentration. mu.L of the above culture medium was applied, and cultured at 28 ℃ for 48 hours to observe colony formation. The concentration corresponding to plates with no longer growing colonies was defined as the minimum inhibitory concentration (Lovato et al, Frontiers in microbiology,2019(10): 2362). The results showed that the MIC of the ethanol extract was 0.5mg/mL and the MIC of the n-butanol re-extract was 0.125 mg/mL.
Example 4
The minimum inhibitory concentration of the 4 plant ethanol extracts on Psa is further determined by using a two-fold dilution method through the inhibitory activity of the ethanol crude extracts of 4 medicinal plants such as fructus forsythiae, liquorice, scutellaria baicalensis and selfheal on Psa. The minimum inhibitory concentration of the ethanol extract of forsythia was found to be 0.5mg/mL for Psa, the minimum inhibitory concentration of licorice and scutellaria was found to be 6.25mg/mL, 2.4mg/mL, and the minimum inhibitory concentration of selfheal was found to be 12.5 mg/mL. The minimum bacteriostatic concentration of the selfheal to Psa is 2 times that of the liquorice and the radix scutellariae, and 4 times that of the fructus forsythiae, so that the inhibition effect of the fructus forsythiae to Psa is stronger than that of the liquorice, the radix scutellariae and the selfheal.
Example 5 field test
The field experiment effect shows that the kiwi fruit tree coated with the forsythia suspense sterilization preparation has better growth vigor, the original branches which do not sprout start to grow new leaves, the disease spots start to be reduced, and no infectious bacterium liquid is seen; the Chinese gooseberry treated by infusion has better growth vigor than Chinese gooseberry trees treated by scraping disease spots and applying medicine. The worst effect is the kiwi fruit tree without scraping the lesion and applying the medicine. In the field experiment process, the infusion treatment is easier to be absorbed by plants, the lesion tissues can be quickly reached, and the loss of the liquid medicine in the treatment process is less, so the treatment effect is most obvious. For the kiwi fruit trees which are scraped and treated by the medicine, the medicine can directly act on the bacterial plaque infection part under the plant epidermis and can be easily absorbed by the plant, so the effect is better. For the kiwi fruit trees which are not scraped with disease spots and are directly coated with the medicine, the medicine is slowly absorbed due to the obstruction of plant epidermis, and the medicine is easily washed by rainwater in rainy days to cause medicine loss, so the effect is obviously poor.
Through field tests, the prevention and control effects of basal application of the bio-organic fertilizer and infusion of the composite bactericide containing the forsythia suspensa extract on the kiwi fruit trees in the winter dormancy stage are preliminarily confirmed.

Claims (6)

1. The fructus forsythiae extract is used for preventing and treating kiwifruit canker caused by pseudomonas syringae kiwifruit pathogenic variety, and is ethanol extract of fructus forsythiae or n-butanol re-extract of ethanol extract of fructus forsythiae.
2. The use according to claim 1, wherein the ethanol extract is obtained by using ethanol with a volume fraction of not less than 75%.
3. Use according to claim 2, characterized in that the ethanol extract uses an extraction solvent of 90-98% ethanol by volume fraction.
4. Use according to claim 3, characterized in that the ethanol extract uses 95% by volume of ethanol as extraction solvent.
5. The use as claimed in claim 1, wherein the n-butanol re-extract of the ethanol extract of forsythia suspensa is prepared by the following method:
(1) leaching the dried and crushed fructus forsythiae with 95% ethanol for 12-24 hours, then ultrasonically extracting at 45-50 ℃ for 4-6 hours to fully leach active ingredients in the fructus forsythiae, and collecting leaching liquor;
(2) concentrating the collected leaching solution to obtain ethanol extract of fructus forsythiae, and recovering ethanol as solvent;
(3) extracting the ethanol extract of fructus forsythiae with n-butanol, and concentrating to obtain n-butanol extract.
6. Use according to claim 5, characterized in that the concentration of the n-butanol extract is carried out by vacuum concentration at 35 ℃.
CN202210217118.4A 2022-03-07 2022-03-07 Application of fructus forsythiae extract in preventing and treating kiwifruit canker Active CN114451425B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202210217118.4A CN114451425B (en) 2022-03-07 2022-03-07 Application of fructus forsythiae extract in preventing and treating kiwifruit canker

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202210217118.4A CN114451425B (en) 2022-03-07 2022-03-07 Application of fructus forsythiae extract in preventing and treating kiwifruit canker

Publications (2)

Publication Number Publication Date
CN114451425A CN114451425A (en) 2022-05-10
CN114451425B true CN114451425B (en) 2022-07-01

Family

ID=81418370

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202210217118.4A Active CN114451425B (en) 2022-03-07 2022-03-07 Application of fructus forsythiae extract in preventing and treating kiwifruit canker

Country Status (1)

Country Link
CN (1) CN114451425B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115067127A (en) * 2022-07-29 2022-09-20 四川佳猕沃农业科技有限公司 Biological control method for kiwifruit canker

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1653910A (en) * 2004-08-30 2005-08-17 刘起麟 Preparation of plant viricidal and antibacterial anti-forge pesticide and application method thereof
JP2009235049A (en) * 2008-03-25 2009-10-15 Yanagi Tomotama Composition for controlling plant pest
CN102197832A (en) * 2011-03-28 2011-09-28 山东大学威海分校 Compound salix leaf preparation and application thereof
KR20190034801A (en) * 2017-09-25 2019-04-03 건국대학교 산학협력단 ANTIBACTERAL COMPOSITION AGAINST PATHOGENIC BACTERIA COMPRISING EXTRACT OF Forsythia suspensa
CN111296494A (en) * 2020-03-03 2020-06-19 安徽审计职业学院 Application of forsythia extract in preventing and controlling agricultural pests

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1653910A (en) * 2004-08-30 2005-08-17 刘起麟 Preparation of plant viricidal and antibacterial anti-forge pesticide and application method thereof
JP2009235049A (en) * 2008-03-25 2009-10-15 Yanagi Tomotama Composition for controlling plant pest
CN102197832A (en) * 2011-03-28 2011-09-28 山东大学威海分校 Compound salix leaf preparation and application thereof
KR20190034801A (en) * 2017-09-25 2019-04-03 건국대학교 산학협력단 ANTIBACTERAL COMPOSITION AGAINST PATHOGENIC BACTERIA COMPRISING EXTRACT OF Forsythia suspensa
CN111296494A (en) * 2020-03-03 2020-06-19 安徽审计职业学院 Application of forsythia extract in preventing and controlling agricultural pests

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
Strategy of tobacco plant against black shank and tobacco mosaic virus infection via induction of PR-1, PR-4 and PR-5 proteins assisted by medicinal plant extracts;Ruoyan Wang et al.;《Physiological and Molecular Plant Pathology》;20170714;第127-145页 *
几种中草药提取物对黄瓜细菌性角斑病菌的抑制作用;崔彦 等;《中国农学通报》;20080531;第24卷(第5期);第308-312页 *
黄芩乙醇提取物对猕猴桃溃疡病致病菌抑菌机理研究;裴沪荣 等;《南方农业学报》;20220228;第53卷(第2期);第477-485页 *

Also Published As

Publication number Publication date
CN114451425A (en) 2022-05-10

Similar Documents

Publication Publication Date Title
CN107446847B (en) Bacillus belgii GT11 and application thereof
CN114451425B (en) Application of fructus forsythiae extract in preventing and treating kiwifruit canker
CN108558499A (en) A kind of compound formulation for melon crop of the extract containing edible fungi residue
CN101518266A (en) Preparation method and application of inula japonica extract and combination thereof
CN113388045A (en) Extraction method of dendrobium officinale with antibacterial effect and compound killing preparation
Leksomboon et al. Potential of plant extracts for controlling citrus canker of lime
CN104886163A (en) Botanical pesticide compound phytolacca acinosa and magnolia officinalis microemulsion and preparation method thereof
CN102283257A (en) Application of elephantopus tomentosus in preventing and treating tobacco bacterial wilt
CN106538610A (en) A kind of purposes of Herba Apii graveolentis stem and leaf extract
CN100571518C (en) The active constituent of curcuma longa of inhibiting and killing plant pathogenic fungi and preparation thereof and application
CN109874811B (en) Natural inhibitor for effectively preventing and treating chrysanthemum root rot and preparation method thereof
CN109303070B (en) Application of mustard extract in preventing and treating watermelon fusarium wilt
CN111676143A (en) Application of Alternaria alternata (Alternaria alternata) in biocontrol of cucurbitaceae
CN108142447B (en) Acalypha australis extract and application thereof as plant antibacterial
CN103060234A (en) Biocontrol strain KMXU28 for controlling paris rhizome root rot and biocontrol agent thereof
CN112106789B (en) Application of delphinium ethyl acetate extract in preventing and treating diamond back moth
CN109090158B (en) Preparation method of medicine for preventing and treating soft rot of konjak prepared from coptis chinensis and prevention and treatment method thereof
CN109090156B (en) Preparation method of konjac soft rot control medicine prepared from scutellaria baicalensis and control method thereof
CN109452324A (en) A kind of composite biological pesticidal preparations for preventing and treating tea tree anthracnose
CN108739864A (en) Plant endogenesis bacteria pesticide and preparation method thereof
CN113082104B (en) Composite antibacterial containing pomegranate peel water extract and pepper seed water extract
NL2031431B1 (en) Compound preparation containing edible mushroom dreg extracts for melon crops
AU2020103248A4 (en) The preparation and application of antifungal extracts from Oxytropis falcate Bunge
CN113603545B (en) Plant nutrition conditioning liquid containing pine needle extract and application thereof
CN113678843B (en) New application of bacillus pumilus LYMC-3

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant